Chemical identity
N-(3-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)phenyl)cinnamamide
CAS not listed · C31H33N3O2S
01Identity
Identifiers and names for this exact compound. Empty fields are left unassigned.
| Lazychem ID | LC-08623 |
|---|---|
| PubChem CID | 135337263 |
| Name | N-(3-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)phenyl)cinnamamide |
| CAS RN | Not listed |
| Molecular formula | C31H33N3O2S |
| Molecular weight | 511.68 g/mol |
| IUPAC name | N-(3-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)phenyl)cinnamamide |
| InChIKey | BADZSNYLKIVZHK-CCEZHUSRSA-N |
02Structure identifiers
![2D structure: N-(3-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)phenyl)cinnamamide](/structures/pubchem/135337263/no-cas-n-3-4-4-benzo-b-thiophen-4-yl-piperazin-1-yl-butoxy-phenyl-cinnamamide-2d-structure-900.png)
Structure facts for this exact identity.
| Molecular formula | C31H33N3O2S |
|---|---|
| InChIKey | BADZSNYLKIVZHK-CCEZHUSRSA-N |
| Ring count | 5 |
| Defined stereocentres | 0 |
| Unassigned stereocentres | 0 |
| SMILES | O=C(/C=C/C1=CC=CC=C1)NC2=CC(OCCCCN3CCN(C4=CC=CC5=C4C=CS5)CC3)=CC=C2 |
|---|---|
| InChI | InChI=1S/C31H33N3O2S/c35-31(15-14-25-8-2-1-3-9-25)32-26-10-6-11-27(24-26)36-22-5-4-17-33-18-20-34(21-19-33)29-12-7-13-30-28(29)16-23-37-30/h1-3,6-16,23-24H,4-5,17-22H2,(H,32,35)/b15-14+ |
03India status for this compound
These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.
| NDPS / RCS | NOT FOUND IN REVIEWED ENTRIES | No CAS number is available for an exact comparison. Generic and analogue entries were not evaluated. |
|---|---|---|
| SCOMET | NOT FOUND IN REVIEWED CAS ENTRIES | No CAS number is available for an exact comparison. Generic and analogue entries were not evaluated. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · source version 1985-09-16
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · source version 2026-03-11
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · source version 2024-09-02
04Names and relationships
Associated parent compound
Brexpiprazole
View API and impurity familyOther names
- Brexpiprazole Impurity 79
05Documented history
Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.
No verified discovery, first report, occurrence, use or issue event is currently available for this identity.
06Sources
- S01PubChem compound record, CID 135337263
Names and machine-readable chemical identity properties.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. This page does not reproduce vendor descriptions or contributed narrative text.
- S03Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S04Controlled-substances notifications and amendments
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S05Appendix 3, SCOMET List
Directorate General of Foreign Trade, Government of India. Used for the exact-compound India status shown on this page.
